Resource Label Group Expands Pharmaceutical Offering With Acquisition of MedLit Solutions

FRANKLIN, Tenn.–(BUSINESS WIRE)–#acquisitions–Resource Label Group, LLC (“Resource Label”), a full-service provider of pressure sensitive labels, shrink sleeve and RFID/NFC technology, announced it has acquired MedLit Solutions, a leader in pharmaceutical packaging and printing solutions. With two locations, in Garner, NC and Winston NJ, MedLit offers end-to-end solutions for the pharmaceutical, biotech, and healthcare industries. For … [Read more…]

Sonendo® Announces Next Generation GentleWave® G4 System

Designed to Improve Patient Workflow, the GentleWave G4 System Is the Latest Innovation from Sonendo LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the release of the GentleWave G4 System, the next generation of its innovative technology platform designed to treat tooth decay. … [Read more…]

Inbound Health Launches to Enable Partners to Build and Scale Hospital and Skilled Nursing Facility-at-Home Care Models

Flare Capital Partners and Allina Health leading $20M fundraising for Inbound Health to scale successful acute care-at-home programs nationally through unique partnership model MINNEAPOLIS–(BUSINESS WIRE)–Allina Health and Flare Capital Partners today announced the launch of Inbound Health, a new company that enables health systems and health plans to offer hospital-at-home and skilled nursing-at-home programs. These … [Read more…]

Acorda Therapeutics Will Not Use Shares for December 2022 $6.2 Million Interest Payment on Secured Debt

PEARL RIVER, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will not use its common stock to make the approximately $6.2 million interest payment due on December 1, 2022, as provided for under its Convertible Senior Secured Notes Indenture. Under the terms of the agreement with bondholders, Acorda may elect to pay interest … [Read more…]

AVROBIO Granted ILAP Designation from U.K. MHRA for First-in-Class Gene Therapy for Gaucher Disease

ILAP intended to accelerate regulatory review process and facilitate patient access in U.K. for seriously debilitating and life-threatening diseases AVR-RD-02 has previously received Fast Track status from U.S. FDA and orphan drug designation in the U.S. and EU CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from … [Read more…]

BioIntelliSense Acquires AlertWatch® Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions

The FDA-cleared AlertWatch® clinical intelligence and triage system spans healthcare settings and seamlessly integrates with BioIntelliSense’s medical-grade BioButton® wearables for scalable in-hospital patient monitoring and at-home remote care Medtronic Patient Monitoring business to offer AlertWatch solution to U.S. Hospitals DENVER–(BUSINESS WIRE)–BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its acquisition of … [Read more…]

International Nonprofit Longevity Science Foundation Expands to the United States with New CEO

The LSF has expanded its global reach to the U.S. with 501(c)3 status, headquarters in Miami, and the appointment of new CEO and Advisory Board members MIAMI–(BUSINESS WIRE)–#biotech—The Longevity Science Foundation (LSF), a global nonprofit organization providing research funding to establish a longer and healthier human lifespan, has recently expanded by launching operations in the … [Read more…]

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders

— Founded on the first and only platform designed to genetically engineer small molecule therapeutics from fungi and plants — — Led by veteran biotech executives Usman Azam, Chief Executive Officer, and Fred Grossman, Chief Medical Officer — NEW YORK & CAMBRIDGE, England–(BUSINESS WIRE)–Empyrean Neuroscience, Inc., a leading genetic engineering company dedicated to developing neuroactive … [Read more…]

Babylon Receives $80 Million in Total Subscriptions for Private Placement Financing

AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) (“Babylon” or the “Company”) today announced that it has received its Board of Directors’ authorized maximum of $80 million in total subscriptions (the “Subscriptions”) from institutional and other accredited investors for its previously announced private investment in public equity (the “PIPE”) at a price of $0.42122 per Class … [Read more…]

ADME-Toxicology Testing Global Market Report 2022: Increased Need to Check Late-Stage Drug Failures Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “ADME-Toxicology Testing – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global ADME-Toxicology Testing Market to Reach $12.3 Billion by 2027 In the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$6 Billion in the year 2020, is projected to reach a revised size … [Read more…]